STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Vita Coco Company, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) notice records a proposed sale under Rule 144 and recent 10b5-1 transactions by an insider. The filer plans to sell 20,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $799,600, representing securities outstanding of 56,822,981 shares, with an approximate sale date of 09/17/2025.

The securities were acquired on 09/17/2025 by exercise of stock options and paid in cash. The filing also discloses two prior 10b5-1 sales this year: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.

Positive

  • Full disclosure of transaction details including dates, amounts, broker, and aggregate market value
  • Prior 10b5-1 sales disclosed, indicating planned trading activity rather than ad hoc insider sales
  • Cash payment on option exercise is stated, clarifying consideration for the acquisition

Negative

  • None.

Insights

TL;DR: Insider exercised options and intends to sell 20,000 shares (~$800k); prior 10b5-1 sales occurred earlier in 2025.

This Form 144 documents a routine insider sale following option exercise and existing 10b5-1 plans. The size of the proposed sale is small relative to the reported 56.8 million shares outstanding, suggesting limited dilution or market impact. The filing confirms cash payment on exercise and provides dates and values for two recent 10b5-1 transactions, which supports a pattern of planned sales rather than opportunistic trading.

TL;DR: Disclosure aligns with Rule 144 requirements; signatures and representations about material nonpublic information are included.

The notice includes the required representation that the seller is unaware of undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable. This procedural compliance is important for governance and insider trading controls. No departures from standard disclosure practices are evident in the content provided.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for COCO disclose?

It discloses a proposed sale of 20,000 common shares valued at $799,600 to be sold on 09/17/2025 through Morgan Stanley Smith Barney.

How were the 20,000 shares acquired according to the filing?

The shares were acquired on 09/17/2025 by exercise of stock options and payment was made in cash.

Has the insider sold other COCO shares recently?

Yes. The filing lists two 10b5-1 sales: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.

What percentage of outstanding shares does the proposed sale represent?

The company reports 56,822,981 shares outstanding; the proposed 20,000 share sale represents a very small fraction of that total.

Which broker will execute the sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004 is listed as the broker.
Vita Coco Company, Inc.

NASDAQ:COCO

COCO Rankings

COCO Latest News

COCO Latest SEC Filings

COCO Stock Data

2.75B
51.44M
10.67%
85.62%
8.23%
Beverages - Non-Alcoholic
Beverages
Link
United States
NEW YORK